CD24-Fc resolves inflammation and rescues CD8 T cells with polyfunctionality in humanized mice infected with HIV-1 under cART
2024

CD24-Fc Helps Fight Inflammation and Boosts Immune Cells in HIV-1 Infected Mice

publication

Author Information

Author(s): Li Guangming, Ma Jianping, Yu Haisheng, Tsahouridis Ourania, Lou Yaoxian, He Xiuting, Funaki Masaya, Mathur Poonam, Kottilil Shyamasundaran, Zheng Pan, Liu Yang, Su Lishan

Primary Institution: Cold Spring Harbor Laboratory

Hypothesis

Can CD24-Fc treatment reduce inflammation and improve immune function in HIV-1 infected humanized mice undergoing cART?

Conclusion

CD24-Fc treatment significantly reduces inflammation and improves the recovery of immune cells in HIV-1 infected mice.

Supporting Evidence

  • CD24-Fc treatment significantly reduced inflammation and immune hyperactivation in vivo.
  • CD24-Fc mediated resolution of inflammation was associated with improved recovery of CD4 T cells.
  • The treatment restored central memory T cells and reversed immune cell exhaustion phenotype.
  • CD24-Fc treatment rescued CXCR5+ CD8 central memory T cells, correlating with increased polyfunctionality in HIV-specific T cells.
  • This restoration was associated with HIV replication inhibition and delayed viral rebound.

Takeaway

This study shows that a special protein called CD24-Fc can help reduce sickness in mice with HIV and make their immune system stronger.

Methodology

The study assessed the effects of CD24-Fc in a chronic HIV-1 infection model using humanized mice undergoing suppressive cART.

Digital Object Identifier (DOI)

10.1101/2024.12.16.628615

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication